2021 Vitiligo International Symposium (VIS)

All times listed below are central time – USA (Chicago, IL). To find the event time in your local time, click here.

December 4, 2021
  • December 4, 2021 5:00 AM CT
    Virtual Poster Session

    Go online, before and after the meeting or anytime to review the submitted academic posters.

    Click here to review the iPosters: Review the iPosters from November 26, 2021 - January 31, 2022.

  • December 4, 2021 06:30 AM CT
    Welcome Message

    The Global Vitiligo Foundation president and the meeting chairs will welcome everyone to the symposium. A brief update about the GVF will be given.

  • December 4, 2021 06:40 AM CT
    Invited Speaker # 1 - Thierry Passeron, MD, PhD

    Oral Gliadin-Protected Superoxide Dismutase in Addition to Phototherapy for Treating Non-segmental Vitiligo: A 24-Week Prospective Randomized Placebo-Controlled Study

    Summary:
    The use of GP-SOD combined with NB-UVB could be a useful add-on in the treatment of vitiligo patients with excellent tolerability and safety.

  • December 4, 2021 7:00 AM CT
    Abstract #1 - Hyun Jeong Ju, MD

    Progressive and Extensive Hypomelanosis of Childhood: A Novel Disease Entity Distinguished from Other Hypomelanotic Disorders

  • December 4, 2021 7:10 AM CT
    Abstract #2 - Marcella Willemsen, MSc

    Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in Peripheral Blood of Segmental and Non-segmental Vitiligo Patients

  • December 4, 2021 7:20 AM CT
    Abstract #3 - Nanja van Geel, MD, PhD

    Image Analyses Systems to Calculate the Surface Area of Vitiligo Lesions: A Systematic Review of Measurement Properties

  • December 4, 2021 7:30 AM CT
    Invited Speaker #2 - Caroline Lapoole, PhD

    Modeling Microbial Impact on Autoimmune Depigmentation in Mice

  • December 4, 2021 7:50 AM CT
    Abstract #4 - Saurabh Bhatia, MD

    Efficacy of NB-UVB in Progressive Versus Non-progressive Non-segmental Vitiligo: A Prospective Comparative Study

  • December 4, 2021 8:00 AM CT
    Abstract #5 - Khaled Ezzedine, MD, PhD

    Efficacy and Safety of the Oral Janus Kinase 3/Tec Inhibitor Ritlecitinib (PF-06651600) In Adults With Active Non-segmental Vitiligo: Results From a Phase 2b, Randomized, Dose-Ranging Study With an Extension Period

  • December 4, 2021 8:10 AM CT
    Demo and Data Share - MyVitiligoTeam
  • December 4, 2021 8:20 AM CT
    Poster Q&A #1

    Join the authors of several scientific posters for an open Q&A session.

  • December 4, 2021 8:40 AM CT
    Invited Speaker #3 - Mauro Picardo, MD

    Vitiligo: A Diverse Perspective

  • December 4, 2021 9:00 AM CT
    Abstract #6 - Nicoline Post, MD

    Meek Micrografting: A Novel Surgical Technique for the Treatment of Depigmentation

  • December 4, 2021 9:10 AM CT
    Abstract #7 - Helen Kitchen, MSc

    A Qualitative Study to Explore the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures

  • December 4, 2021 9:20 AM CT
    Abstract #8 - Camille Robinson, BS

    Assessment of Vitiligo Patients’ Perceptions and Opinions About Their Dermatologists When They Were First Diagnosed

  • December 4, 2021 9:30 AM CT
    Invited Speaker #4 - Marcella Willemsen, MSc

    Impaired Ifn-γ-Induced PD-L1 Expression on Human Vitiligo Melanocytes

  • December 4, 2021 9:50 AM CT
    Poster Q&A #2

    Join the authors of several scientific posters for an open Q&A session.

  • December 4, 2021 10:20 AM CT
    Wrap up and Summary of the Day

    Join the chairs as the highlight some of the top topics of the day.

  • December 4, 2021 10:20 AM CT
    Virtual Poster Session

    Go online, before and after the meeting or anytime to review the submitted academic posters.

    Click here to review the iPosters: Review the iPosters from November 26, 2021 - January 31, 2022.

December 5, 2021
Event Details
  • Days
    Hours
    Min
    Sec
  • Start Date
    December 4, 2021 6:30 am
  • End Date
    December 5, 2021 10:30 am
  • Status
    Upcoming